Stryker Corporation logo

Stryker Corporation (SYK)

Market Open
5 Dec, 17:16
NYSE NYSE
$
365. 09
+0.74
+0.2%
$
141.94B Market Cap
43.11 P/E Ratio
3.2% Div Yield
349,481 Volume
10.41 Eps
$ 364.35
Previous Close
Day Range
364.49 368.24
Year Range
329.16 406.19
Want to track SYK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 52 days
Stryker Stock Gains 18.6% YTD: What's Driving its Share Price?

Stryker Stock Gains 18.6% YTD: What's Driving its Share Price?

Styker's flagship, Mako Total Knee Platform, its strategic acquisitions and a diversified product portfolio raise optimism about the stock.

Zacks | 1 year ago
SYK Stock May Gain From Completion of Vertos Medical Acquisition

SYK Stock May Gain From Completion of Vertos Medical Acquisition

Stryker completes the acquisition of Vertos Medical to expand its interventional pain management solutions.

Zacks | 1 year ago
Reasons to Retain Stryker Stock in Your Portfolio for Now

Reasons to Retain Stryker Stock in Your Portfolio for Now

SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.

Zacks | 1 year ago
Stryker Shares May Gain on the Completion of the Acquisition of NICO

Stryker Shares May Gain on the Completion of the Acquisition of NICO

SYK completes the acquisition of NICO to strengthen its portfolio of solutions for tumor resection and the treatment of ICH.

Zacks | 1 year ago
Stryker Stock Declines Despite Completion of care.ai Acquisition

Stryker Stock Declines Despite Completion of care.ai Acquisition

SYK completes the acquisition of care.ai, adding AI-based workflows and smart room technology to its portfolio to overcome nursing shortages, and improve staff retention and workplace safety.

Zacks | 1 year ago
SYK Stocks Gains Following Expansion of Foot & Ankle Portfolio

SYK Stocks Gains Following Expansion of Foot & Ankle Portfolio

Stryker unveils two new products, enhancing precision and outcomes in foot and ankle surgeries.

Zacks | 1 year ago
Stryker Corporation (SYK) Wells Fargo 2024 Healthcare Conference (Transcript)

Stryker Corporation (SYK) Wells Fargo 2024 Healthcare Conference (Transcript)

Stryker Corporation (NYSE:SYK ) Wells Fargo 2024 Healthcare Conference Call September 5, 2024 3:00 PM ET Company Participants Spencer Stiles - Group President, Orthopedics and Spine Jason Beach - Vice President, Investor Relations Conference Call Participants Larry Biegelsen - Wells Fargo All right, welcome back. I'm Larry Biegelsen, the medical device analyst at Wells Fargo.

Seekingalpha | 1 year ago
Why Is Stryker (SYK) Up 8.8% Since Last Earnings Report?

Why Is Stryker (SYK) Up 8.8% Since Last Earnings Report?

Stryker (SYK) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Stryker Rallies 19.8% Year to Date: What's Driving the Stock?

Stryker Rallies 19.8% Year to Date: What's Driving the Stock?

SYK's flagship Mako Total Knee Platform, its strategic acquisitions and a diversified product portfolio raise optimism about the stock.

Zacks | 1 year ago
Reasons to Retain Stryker Stock in Your Portfolio for Now

Reasons to Retain Stryker Stock in Your Portfolio for Now

SYK continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio.

Zacks | 1 year ago
Stryker's (SYK) Inks Deal to Aid Its Pain Management Portfolio

Stryker's (SYK) Inks Deal to Aid Its Pain Management Portfolio

Stryker (SYK) is set to acquire Vertos Medical to expand its interventional pain management portfolio.

Zacks | 1 year ago
Stryker (SYK) to Acquire care.ai to Boost AI-Driven Healthcare

Stryker (SYK) to Acquire care.ai to Boost AI-Driven Healthcare

Stryker's (SYK) acquisition of care.ai is set to enhance its healthcare IT offerings with AI-assisted virtual care workflows and smart room technology.

Zacks | 1 year ago
Loading...
Load More